Neurocrine Biosciences, Inc. NBIX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -33.81% | -60.05% | 39.50% | 37.57% | -9.22% |
| Total Receivables | 31.73% | 48.90% | 48.86% | 43.35% | 51.32% |
| Inventory | -4.62% | 83.13% | 9.14% | 20.21% | 51.31% |
| Prepaid Expenses | 19.26% | -- | -- | 251.96% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -51.91% | -67.36% | -47.61% | 82.08% | -43.96% |
| Total Current Assets | -6.96% | -6.37% | 48.73% | 46.27% | 15.02% |
|
|
|||||
| Total Current Assets | -6.96% | -6.37% | 48.73% | 46.27% | 15.02% |
| Net Property, Plant & Equipment | -6.50% | -7.79% | -8.69% | -7.91% | 67.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6,037.25% | 5,883.87% | -- | -- | 3.48% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -35.34% | -61.09% | -11.60% | -29.37% | -23.75% |
| Total Assets | 31.92% | 37.77% | 33.04% | 24.55% | 20.67% |
|
|
|||||
| Total Accounts Payable | 25.52% | 35.76% | 9.09% | 5.01% | 25.29% |
| Total Accrued Expenses | 34.11% | 53.59% | 37.32% | 42.56% | 56.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.98% | 17.95% | 25.66% | -- | 47.41% |
| Total Finance Division Other Current Liabilities | 6,225.00% | 280.50% | 582.91% | 44.56% | 9.09% |
| Total Other Current Liabilities | 6,225.00% | 280.50% | 582.91% | 44.56% | 9.09% |
| Total Current Liabilities | 54.33% | 60.08% | 59.06% | 46.43% | 48.48% |
|
|
|||||
| Total Current Liabilities | 54.33% | 60.08% | 59.06% | 46.43% | 48.48% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.43% | -8.49% | -9.23% | -8.75% | 70.41% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 89.98% | 85.25% | 43.67% | 32.19% | 44.96% |
| Total Liabilities | 38.55% | 39.31% | 30.10% | 22.09% | 54.65% |
|
|
|||||
| Common Stock & APIC | 12.59% | 14.14% | 11.27% | 9.30% | 2.79% |
| Retained Earnings | 185.17% | 756.80% | 11,224.53% | 1,433.22% | 262.52% |
| Treasury Stock & Other | -66.67% | -59.20% | -95.56% | 125.86% | -8.97% |
| Total Common Equity | 29.14% | 37.09% | 34.38% | 25.62% | 10.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.14% | 37.09% | 34.38% | 25.62% | 10.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.14% | 37.09% | 34.38% | 25.62% | 10.47% |
|
|
|||||